Funds and ETFs McKesson Corporation

Equities

MCK

US58155Q1031

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-05-10 pm EDT 5-day change 1st Jan Change
559.9 USD +0.86% Intraday chart for McKesson Corporation +5.87% +20.94%

ETFs positioned on McKesson Corporation

Name Weight AuM 1st Jan change Investor Rating
0.18% 0 M€ +5.63% -
0.18% 0 M€ +1.41% -
0.18% 0 M€ +5.63% -
0.18% 0 M€ +9.42%
0.17% 6 M€ +17.98% -
0.17% 0 M€ +6.97% -
0.15% 0 M€ +11.62% -
0.15% 1 M€ -.--%
0.14% 0 M€ +20.04% -
0.13% 23 M€ -.--% -
0.13% 786 M€ -.--%
0.12% 206 M€ -.--%
0.11% 0 M€ +12.13% -
0.11% 14 M€ +16.19% -
0.10% 0 M€ +18.92%
0.10% 0 M€ +9.18% -
0.10% 1,166 M€ +0.26%
0.10% 607 M€ +0.05%
0.10% 0 M€ 0.00% -
0.09% 0 M€ +6.85% -
0.08% 0 M€ +8.70% -
0.08% 0 M€ +8.24% -
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (87%); - distribution of medical and surgical products (4%); - other (1.6%): primarily technology services and software sales. The remaining net sales (7.4%) are from international activities.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
559.9 USD
Average target price
579.9 USD
Spread / Average Target
+3.57%
Consensus
  1. Stock Market
  2. Equities
  3. MCK Stock
  4. Funds and ETFs McKesson Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW